Annual Total Long Term Liabilities
$1.41 M
+$1.20 M+569.19%
December 31, 2023
Summary
- As of March 6, 2025, VYNE annual total long term liabilities is $1.41 million, with the most recent change of +$1.20 million (+569.19%) on December 31, 2023.
- During the last 3 years, VYNE annual total long term liabilities has fallen by -$33.07 million (-95.91%).
- VYNE annual total long term liabilities is now -98.78% below its all-time high of $116.08 million, reached on December 31, 2017.
Performance
VYNE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
-$25.00 K-100.00%
September 30, 2024
Summary
- As of March 6, 2025, VYNE quarterly total long term liabilities is $0.00, with the most recent change of -$25.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, VYNE quarterly long term liabilities has stayed the same.
- VYNE quarterly long term liabilities is now -100.00% below its all-time high of $116.54 million, reached on September 30, 2017.
Performance
VYNE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VYNE Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +569.2% | 0.0% |
| 3 y3 years | -95.9% | -100.0% |
| 5 y5 years | +10000.0% | -100.0% |
VYNE Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -100.0% | at low |
| 5 y | 5-year | -95.9% | -100.0% | -100.0% | at low |
| alltime | all time | -98.8% | -100.0% | -100.0% | at low |
VYNE Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $25.00 K(-98.2%) |
| Mar 2024 | - | $1.38 M(-2.5%) |
| Dec 2023 | $1.41 M(+569.2%) | $1.41 M(+7.5%) |
| Sep 2023 | - | $1.31 M(0.0%) |
| Jun 2023 | - | $1.31 M(0.0%) |
| Mar 2023 | - | $1.31 M(+522.3%) |
| Dec 2022 | $211.00 K(>+9900.0%) | $211.00 K(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2021 | - | $1.43 M(-2.6%) |
| Jun 2021 | - | $1.47 M(-95.8%) |
| Mar 2021 | - | $34.72 M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $34.48 M(>+9900.0%) | $34.48 M(-1.4%) |
| Sep 2020 | - | $34.98 M(-0.3%) |
| Jun 2020 | - | $35.08 M(+1.9%) |
| Mar 2020 | - | $34.41 M(>+9900.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2019 | - | $122.00 K(-59.5%) |
| Jun 2019 | - | $301.00 K(>+9900.0%) |
| Mar 2019 | - | $0.00(-100.0%) |
| Dec 2018 | $7000.00(-100.0%) | $7000.00(-41.7%) |
| Sep 2018 | - | $12.00 K(-84.6%) |
| Jun 2018 | - | $78.00 K(-98.8%) |
| Mar 2018 | - | $6.31 M(-94.6%) |
| Dec 2017 | $116.08 M(+71.7%) | $116.08 M(-0.4%) |
| Sep 2017 | - | $116.54 M(+72.4%) |
| Dec 2016 | $67.59 M(+14.4%) | $67.59 M |
| Dec 2015 | $59.07 M | - |
FAQ
- What is VYNE Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for VYNE Therapeutics?
- What is VYNE Therapeutics annual total long term liabilities year-on-year change?
- What is VYNE Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly long term liabilities year-on-year change?
What is VYNE Therapeutics annual total long term liabilities?
The current annual total long term liabilities of VYNE is $1.41 M
What is the all time high annual total long term liabilities for VYNE Therapeutics?
VYNE Therapeutics all-time high annual total long term liabilities is $116.08 M
What is VYNE Therapeutics annual total long term liabilities year-on-year change?
Over the past year, VYNE annual total long term liabilities has changed by +$1.20 M (+569.19%)
What is VYNE Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of VYNE is $0.00
What is the all time high quarterly long term liabilities for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly total long term liabilities is $116.54 M
What is VYNE Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, VYNE quarterly total long term liabilities has changed by $0.00 (0.00%)